Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Current Assets (2018 - 2025)

Historic Current Assets for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $30.3 million.

  • Dna X's Current Assets fell 1052.15% to $30.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.3 million, marking a year-over-year decrease of 1052.15%. This contributed to the annual value of $32.2 million for FY2024, which is 2654.21% down from last year.
  • Latest data reveals that Dna X reported Current Assets of $30.3 million as of Q3 2025, which was down 1052.15% from $27.1 million recorded in Q2 2025.
  • Over the past 5 years, Dna X's Current Assets peaked at $47.5 million during Q3 2023, and registered a low of $26.9 million during Q1 2025.
  • Over the past 5 years, Dna X's median Current Assets value was $33.9 million (recorded in 2024), while the average stood at $35.7 million.
  • Per our database at Business Quant, Dna X's Current Assets tumbled by 4303.59% in 2021 and then soared by 3941.88% in 2023.
  • Quarter analysis of 5 years shows Dna X's Current Assets stood at $35.7 million in 2021, then rose by 22.26% to $43.6 million in 2022, then rose by 0.36% to $43.8 million in 2023, then decreased by 26.54% to $32.2 million in 2024, then decreased by 5.8% to $30.3 million in 2025.
  • Its Current Assets stands at $30.3 million for Q3 2025, versus $27.1 million for Q2 2025 and $26.9 million for Q1 2025.